Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Nova Eye Medical ( (AU:EYE) ) just unveiled an update.
Nova Eye Medical Limited has announced a change in the director’s interest, specifically concerning Victor Previn. The change involves an indirect interest through Sedico Pty Ltd as trustee, with an acquisition of 416,666 ordinary securities valued at $49,999.92, approved at a general meeting on 19 March 2025. This adjustment in director’s interest reflects the company’s ongoing governance and compliance with ASX listing rules.
More about Nova Eye Medical
Technical Sentiment Signal: Buy
Current Market Cap: $16.81M
For an in-depth examination of EYE stock, go to TipRanks’ Stock Analysis page.